US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

CYT

Cyteir Therapeutics (CYT)

Cyteir Therapeutics Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CYT

Fecha	Hora	Fuente	Título	Símbolo	Compañía
07/03/2024	15:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYT	Cyteir Therapeutics Inc
07/03/2024	15:30	Business Wire	Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq	NASDAQ:CYT	Cyteir Therapeutics Inc
05/03/2024	17:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYT	Cyteir Therapeutics Inc
14/02/2024	18:36	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CYT	Cyteir Therapeutics Inc
06/11/2023	15:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CYT	Cyteir Therapeutics Inc
12/10/2023	15:14	Edgar (US Regulatory)	Form DEFM14A - Definitive proxy statement relating to merger or acquisition	NASDAQ:CYT	Cyteir Therapeutics Inc
12/10/2023	06:52	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:CYT	Cyteir Therapeutics Inc
12/10/2023	06:30	Business Wire	Ongoing Results From a Dose Expansion Cohort of CYT-0851 in Combination With Capecitabine in Advanced Platinum-Resistant Ovarian Cancer Show Promising Clinical Activity and Generally Well Tolerated Safety Profile	NASDAQ:CYT	Cyteir Therapeutics Inc
02/10/2023	15:44	Edgar (US Regulatory)	Form PREM14A - Preliminary proxy statements relating to merger or acquisition	NASDAQ:CYT	Cyteir Therapeutics Inc
30/06/2023	16:29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CYT	Cyteir Therapeutics Inc
30/06/2023	09:38	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CYT	Cyteir Therapeutics Inc
30/06/2023	09:22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CYT	Cyteir Therapeutics Inc
30/06/2023	07:00	Business Wire	Cyteir Therapeutics Announces Discontinuation of CYT-0851 Development Program and Planned Liquidation and Dissolution	NASDAQ:CYT	Cyteir Therapeutics Inc
28/06/2023	17:03	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:CYT	Cyteir Therapeutics Inc
20/06/2023	16:54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CYT	Cyteir Therapeutics Inc
03/06/2023	08:00	Business Wire	Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Clinical Activity and Generally Well Tolerated Safety Profile	NASDAQ:CYT	Cyteir Therapeutics Inc
10/05/2023	15:01	Business Wire	Cyteir Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights	NASDAQ:CYT	Cyteir Therapeutics Inc
27/04/2023	15:23	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:CYT	Cyteir Therapeutics Inc
27/04/2023	15:10	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CYT	Cyteir Therapeutics Inc
23/03/2023	15:24	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CYT	Cyteir Therapeutics Inc
23/03/2023	15:17	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CYT	Cyteir Therapeutics Inc
23/03/2023	15:01	Business Wire	Cyteir Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights	NASDAQ:CYT	Cyteir Therapeutics Inc
14/02/2023	13:43	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CYT	Cyteir Therapeutics Inc
06/02/2023	07:15	Business Wire	Cyteir Therapeutics Promotes David Gaiero to Chief Financial Officer	NASDAQ:CYT	Cyteir Therapeutics Inc
03/02/2023	15:07	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:CYT	Cyteir Therapeutics Inc
19/01/2023	15:30	Business Wire	Cyteir Therapeutics Announces Prioritization of CYT-0851 Development and Extended Cash Runway	NASDAQ:CYT	Cyteir Therapeutics Inc
07/11/2022	15:10	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CYT	Cyteir Therapeutics Inc
07/11/2022	15:01	Business Wire	Cyteir Therapeutics Reports Third Quarter 2022 Financial Results and Operational Highlights	NASDAQ:CYT	Cyteir Therapeutics Inc
12/10/2022	07:00	Business Wire	Cyteir Therapeutics Presents Poster on the Identification of Mechanism of Action of CYT-0851 at the 34th Annual EORTC-NCI-AACR Symposium	NASDAQ:CYT	Cyteir Therapeutics Inc
31/08/2022	06:30	Business Wire	Cyteir Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference	NASDAQ:CYT	Cyteir Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:CYT

BNP Paribas Issuance

Clinuvel Pharmaceuticals

Sigma Fin.frn11

STELLAR ACQUISITION III INC.

HSBC Global Investment F...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones